share_log

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Arcutis Biotherapeutics | 144：擬議出售證券

SEC announcement ·  03/04 17:43
Moomoo AI 已提取核心訊息
Arcutis Biotherapeutics, Inc. officer Patrick Burnett is set to sell 4,782 shares of common stock on 03/04/2024, as per the latest filing. The shares to be sold have an aggregate market value of $53,181. Burnett acquired these shares through restricted stock vesting on two separate dates, with 3,855 shares vested on 03/01/2024 and an additional 927 shares on 03/03/2024, both from Arcutis Biotherapeutics. This transaction follows a previous sale of 1,325 shares in the past three months, which had gross proceeds of $4,691.
Arcutis Biotherapeutics, Inc. officer Patrick Burnett is set to sell 4,782 shares of common stock on 03/04/2024, as per the latest filing. The shares to be sold have an aggregate market value of $53,181. Burnett acquired these shares through restricted stock vesting on two separate dates, with 3,855 shares vested on 03/01/2024 and an additional 927 shares on 03/03/2024, both from Arcutis Biotherapeutics. This transaction follows a previous sale of 1,325 shares in the past three months, which had gross proceeds of $4,691.
根據最新文件，Arcutis Biotherapeutics, Inc.高管帕特里克·伯內特定於2024年4月3日出售4,782股普通股。待售股票的總市值爲53,181美元。伯內特在兩個不同的日期通過限制性股票歸屬收購了這些股票，其中3,855股於2024年1月3日歸屬，另有927股股票於2024年3月3日歸屬，均來自Arcutis Biotherapeutics。該交易是在過去三個月中出售1,325股股票之後進行的，總收益爲4,691美元。
根據最新文件，Arcutis Biotherapeutics, Inc.高管帕特里克·伯內特定於2024年4月3日出售4,782股普通股。待售股票的總市值爲53,181美元。伯內特在兩個不同的日期通過限制性股票歸屬收購了這些股票，其中3,855股於2024年1月3日歸屬，另有927股股票於2024年3月3日歸屬，均來自Arcutis Biotherapeutics。該交易是在過去三個月中出售1,325股股票之後進行的，總收益爲4,691美元。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息